Seven Eight Capital’s Pediatrix Medical MD Stock Holding History

Seven Eight Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-66,200	Closed	-$771K	–	480
2020 Q1	$771K	Sell	66,200 -4,778	-7%	-$98.5K	0.2%	152
2019 Q4	$1.97M	Buy	70,978 +32,700	+85%	+$820K	0.1%	303
2019 Q3	$866K	Sell	38,278 -12,028	-24%	-$274K	0.05%	446
2019 Q2	$1.27M	Sell	50,306 -55,000	-52%	-$1.48M	0.07%	356
2019 Q1	$2.86M	Buy	105,306 +57,000	+118%	+$1.91M	0.15%	192
2018 Q4	$1.59M	Sell	48,306 -3,000	-6%	-$121K	0.09%	281
2018 Q3	$2.39M	Buy	+51,306	New	+$2.36M	0.15%	213
2015 Q1	–	Sell	-160	Closed	-$11K	–	607
2014 Q4	$11K	Sell	160 -1,540	-91%	-$94K	0.02%	389
2014 Q3	$93.2K	Buy	+1,700	New	+$96.5K	0.07%	335

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Seven Eight Capital's MD Position: Q2 2020 in Review

Seven Eight Capital sold out of Pediatrix Medical (MD) in Q2 2020, closing a stake of 66,200 shares — an estimated $771K sold.

Seven Eight Capital first reported a position in MD in Q3 2014 and held it in 9 quarters. The position peaked at $2.86M in Q1 2019. 215 funds tracked by Wall St. Rank hold MD as of Q2 2020.

Seven Eight Capital reported no remaining Pediatrix Medical position as of Q2 2020 after selling out during the quarter.
Seven Eight Capital sold 66,200 Pediatrix Medical shares in Q2 2020, an estimated $771K.
Seven Eight Capital first reported a position in Pediatrix Medical in Q3 2014 and held it in 9 quarters.
Seven Eight Capital's Pediatrix Medical position peaked at $2.86M in Q1 2019.
215 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2020.

Based on Seven Eight Capital's 13F filing for Q2 2020, filed 6 Aug 2020.